Lipid Encapsulation for Ileal Brake Activation
- Conditions
- Appetite Regulation
- Interventions
- Dietary Supplement: Active yoghurtDietary Supplement: Placebo yoghurt
- Registration Number
- NCT03025997
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
This study evaluates the ability of encapsulation of orally applied lipids in a yoghurt snack to modify ad libitum food intake and satiety, without GI symptoms. Every subject receives two treatments (active, and placebo) on two different days, following a randomized cross-over design.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 33
- BMI between 25-30 kg/m2
- Voluntary participation
- Milk (-protein or lactose)- allergy/intolerance
- History of serious GI complaints/surgeries
- Pregnancy, lactation
- Excessive alcohol consumption (>20 per week)
- Abnormal eating behaviour
- Intention to stop smoking
- Reported unexplained weight loss or gain in the month prior to screening
- Self-admitted HIV-positive state
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Active yoghurt Active yoghurt Yoghurt snack containing encapsulated lipid Placebo yoghurt Placebo yoghurt Yoghurt snack containing non-encapsulated lipid + empty encapsulation matrix
- Primary Outcome Measures
Name Time Method ad libitum food intake 2 hours after yoghurt snack t=0: standardized breakfast, t=90 minutes: yoghurt, t=210 minutes: ad libitum food intake
- Secondary Outcome Measures
Name Time Method Satiety feelings Up to 3.5 hours on each of the 2 test days. Every 15-30 min, 5 attributes will be measured on a Visual Analogue Scale
occurrence and severity of GI symptoms Up to 3.5 hours on each of the 2 test days. Every 15-30 min, 4 attributes will be measured on a Visual Analogue Scale
Trial Locations
- Locations (1)
Maastricht University
🇳🇱Maastricht, Netherlands